<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33761983</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1752-1947</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>15</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical case reports</Title>
          <ISOAbbreviation>J Med Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Addison's disease associated with hypokalemia: a case report.</ArticleTitle>
        <Pagination>
          <StartPage>131</StartPage>
          <MedlinePgn>131</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">131</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-021-02724-6</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Primary adrenal insufficiency (Addison's disease) is a rare medical condition usually associated with hyperkalemia or normokalemia. We report a rare case of Addison's disease, coexisting with hypokalemia, requiring treatment.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">In this case, a 42-year-old man was admitted to the intensive care unit with a history of loss of consciousness and severe hypoglycemia. His blood tests showed metabolic acidosis, low concentrations of cortisol 6 nmol/L (normal 68-327 nmol/L), and high plasma adrenocorticotropic hormone 253 pmol/L (normal 1.6-13.9 pmol/L), and he was diagnosed with primary adrenal insufficiency. Surprisingly, his serum potassium was low, 2.3 mmol/L (normal 3.5-5.1 mmol/L), requiring replacement over the course of his admission. Computed tomography scan of the adrenal glands showed features suggestive of unilateral adrenal tuberculosis. Investigations confirmed renal tubulopathy. The patient responded favorably to cortisol replacement, but never required fludrocortisone.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Coexistence of hypokalemia with Addison's disease is unusual. We recommend investigation of the cause of hypokalemia in its own right, if it occurs with primary adrenal insufficiency.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abdalla</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Private Bag X3, J47-85 Old Main Building, Observatory, Cape Town, 7935, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dave</LastName>
            <ForeName>J A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Private Bag X3, J47-85 Old Main Building, Observatory, Cape Town, 7935, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ross</LastName>
            <ForeName>I L</ForeName>
            <Initials>IL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Endocrinology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Private Bag X3, J47-85 Old Main Building, Observatory, Cape Town, 7935, South Africa. ian.ross@uct.ac.za.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Med Case Rep</MedlineTA>
        <NlmUniqueID>101293382</NlmUniqueID>
        <ISSNLinking>1752-1947</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>U0476M545B</RegistryNumber>
          <NameOfSubstance UI="D005438">Fludrocortisone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>WI4X0X7BPJ</RegistryNumber>
          <NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000224" MajorTopicYN="Y">Addison Disease</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000311" MajorTopicYN="N">Adrenal Glands</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005438" MajorTopicYN="N">Fludrocortisone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007008" MajorTopicYN="Y">Hypokalemia</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Addison’s disease</Keyword>
        <Keyword MajorTopicYN="N">Hypokalemia</Keyword>
        <Keyword MajorTopicYN="N">Tubulopathy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>25</Day>
          <Hour>5</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33761983</ArticleId>
        <ArticleId IdType="pmc">PMC7992934</ArticleId>
        <ArticleId IdType="doi">10.1186/s13256-021-02724-6</ArticleId>
        <ArticleId IdType="pii">10.1186/s13256-021-02724-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, et al.  Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010;162(3):597–602. doi: 10.1530/EJE-09-0884.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/EJE-09-0884</ArticleId>
            <ArticleId IdType="pubmed">19955259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnett AH, Espiner EA, Donald RA. Patients presenting with Addison’s disease need not be pigmented. Postgrad Med J. 1982;58(685):690–692. doi: 10.1136/pgmj.58.685.690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/pgmj.58.685.690</ArticleId>
            <ArticleId IdType="pmc">PMC2426562</ArticleId>
            <ArticleId IdType="pubmed">7170268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zelissen PMJ, Bast EJEG, Croughs RJM. Associated autoimmunity in Addison’s disease. J Autoimmun. 1995;8(1):121–130. doi: 10.1006/jaut.1995.0009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/jaut.1995.0009</ArticleId>
            <ArticleId IdType="pubmed">7734032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216–226. doi: 10.1016/S2213-8587(14)70142-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2213-8587(14)70142-1</ArticleId>
            <ArticleId IdType="pubmed">25098712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al.  Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–389. doi: 10.1210/jc.2015-1710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2015-1710</ArticleId>
            <ArticleId IdType="pmc">PMC4880116</ArticleId>
            <ArticleId IdType="pubmed">26760044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishikawa S, Schrier RW. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. Kidney Int. 1982;22(6):587–593. doi: 10.1038/ki.1982.216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.1982.216</ArticleId>
            <ArticleId IdType="pubmed">7162034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980;17(1):118–134. doi: 10.1038/ki.1980.14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ki.1980.14</ArticleId>
            <ArticleId IdType="pubmed">6990088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sævik B, Åkerman AK, Grønning K, Nermoen I, Valland SF, Finnes TE, et al.  Clues for early detection of autoimmune Addison’s disease—myths and realities. J Intern Med. 2018;283(2):190–199. doi: 10.1111/joim.12699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/joim.12699</ArticleId>
            <ArticleId IdType="pubmed">29098731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer LG, Frindt G. Regulation of apical K channels in rat cortical collecting tubule during changes in dietary K intake. Am J Physiol Ren Physiol. 1999;277(5 46-5):805–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10564246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross IL, Levitt NS. Addison’s disease symptoms—a cross sectional study in urban South Africa. PLoS ONE. 2013;8(1):9. doi: 10.1371/journal.pone.0053526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0053526</ArticleId>
            <ArticleId IdType="pmc">PMC3538548</ArticleId>
            <ArticleId IdType="pubmed">23308244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seyberth HW. Pathophysiology and clinical presentations of salt-losing tubulopathies. Pediatr Nephrol. 2016;31(3):407–418. doi: 10.1007/s00467-015-3143-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-015-3143-1</ArticleId>
            <ArticleId IdType="pubmed">26178649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, et al.  Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(1):42–61. doi: 10.1016/j.kint.2019.09.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.kint.2019.09.018</ArticleId>
            <ArticleId IdType="pubmed">31706619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Article SEER. Urine tests for chronic hypokalemia : when in doubt , check urine-sodium-to-chloride ratio. Am J Med. 130(7):761–2. 10.1016/j.amjmed.2017.02.040</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28359722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiederseiner JM, Muser J, Lutz T, Hulter HN, Krapf R. Acute metabolic acidosis: characterization and diagnosis of the disorder and the plasma potassium response. J Am Soc Nephrol. 2004;15(6):1589–1596. doi: 10.1097/01.ASN.0000125677.06809.37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.ASN.0000125677.06809.37</ArticleId>
            <ArticleId IdType="pubmed">15153570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGuire LC, Cruickshank AM, Munro PT. Alcoholic ketoacidosis. Emerg Med J. 2006;23(6):417–420. doi: 10.1136/emj.2004.017590.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/emj.2004.017590</ArticleId>
            <ArticleId IdType="pmc">PMC2564331</ArticleId>
            <ArticleId IdType="pubmed">16714496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Downie ML, Lopez Garcia SC, Kleta R, Bockenhauer D. Inherited tubulopathies of the kidney. Clin J Am Soc Nephrol. 2020;4:14481119. doi: 10.2215/CJN.14481119.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2215/CJN.14481119</ArticleId>
            <ArticleId IdType="pubmed">32238367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmer BF. A physiologic-based approach to the evaluation of a patient with hypokalemia. Am J Kidney Dis. 2010;56(6):1184–1190. doi: 10.1053/j.ajkd.2010.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2010.07.010</ArticleId>
            <ArticleId IdType="pubmed">20828906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross I, Boulle A, Soule S, Levitt N, Pirie F, Karlsson A, et al.  Autoimmunity predominates in a large South African cohort with Addison’s disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201. Clin Endocrinol (Oxf). 2010;73(3):291–298. doi: 10.1111/j.1365-2265.2010.03807.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2265.2010.03807.x</ArticleId>
            <ArticleId IdType="pubmed">20455895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Min HK, Kim EO, Lee SJ, Chang YK, Suh KS, Yang CW, et al.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis. BMC Nephrol. 2013;14(1):1. doi: 10.1186/1471-2369-14-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2369-14-13</ArticleId>
            <ArticleId IdType="pmc">PMC3558351</ArticleId>
            <ArticleId IdType="pubmed">23320835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam KY, Lo CY. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf). 2001;54(5):633–639. doi: 10.1046/j.1365-2265.2001.01266.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2265.2001.01266.x</ArticleId>
            <ArticleId IdType="pubmed">11380494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vita JA, Silverberg SJ, Goland RS, Austin JHM, Knowlton AI. Clinical clues to the cause of Addison’s disease. Am J Med. 1985;78(3):461–466. doi: 10.1016/0002-9343(85)90339-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9343(85)90339-0</ArticleId>
            <ArticleId IdType="pubmed">3976705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang ZG, Guo YK, Li Y, Min PQ, Yu JQ, Ma ES. Differentiation between tuberculosis and primary tumors in the adrenal gland: evaluation with contrast-enhanced CT. Eur Radiol. 2006;16(9):2031–2036. doi: 10.1007/s00330-005-0096-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00330-005-0096-y</ArticleId>
            <ArticleId IdType="pubmed">16435135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo YK, Yang ZG, Li Y, Ma E Sen, Deng YP, Min PQ, et al. Addison’s disease due to adrenal tuberculosis: contrast-enhanced CT features and clinical duration correlation. Eur J Radiol. 2007;62(1):126–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17182208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laureti S, Aubourg P, Calcinaro F, Rocchiccioli F, Casucci G, Angeletti G, et al.  Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers. J Clin Endocrinol Metab. 1998;83(9):3163–3168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9745420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al.  Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–2559. doi: 10.1210/jc.2009-2354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2009-2354</ArticleId>
            <ArticleId IdType="pubmed">20525905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayes F, Dwyer A, Pitteloud N. Hypogonadotropic Hypogonadism (HH) and Gonadotropin Therapy. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth: MDTextcom Inc; 2000</Citation>
        </Reference>
        <Reference>
          <Citation>Ross IL, Levitt NS, Blom DJ, Haarburger D. Male and female hypogonadism are highly prevalent in South Africans with Addison’s disease. Horm Metab Res. 2014;46(10):691–696. doi: 10.1055/s-0034-1374589.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0034-1374589</ArticleId>
            <ArticleId IdType="pubmed">24799025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, et al.  Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison’s disease, and premature ovarian failure. J Clin Endocrinol Metab. 1996;81(5):1871–1876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8626850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spencer CA, Lopresti JS, Patel A, Guttler RB, Eigen A, Shen D, et al.  Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab. 1990;70(2):453–460. doi: 10.1210/jcem-70-2-453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem-70-2-453</ArticleId>
            <ArticleId IdType="pubmed">2105333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigues CA, Lennard-Jones J, Thompson DG, Farthing MJG. Serum TSH and thyroid antibody studies in Addison’s diseases. Serum. 2008;2007:1097014–1097014.</Citation>
        </Reference>
        <Reference>
          <Citation>Samuels MH. Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study. J Clin Endocrinol Metab. 2000;85(4):1388–1393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10770171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stryker TD, Molitch ME, Stryker TD, Molitch ME. Reversible hyperthyrotropinemia, hyperthyroxinemia, and hyperprolactinemia due to adrenal insufficiency. Am J Med. 1985;79(2):271–276. doi: 10.1016/0002-9343(85)90022-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0002-9343(85)90022-1</ArticleId>
            <ArticleId IdType="pubmed">4025380</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
